Arterial disease and venous thromboembolism: A modern paradigm?

References
1 Choudhury A, Lip GYH. Atrial fibrillation and the hypercoagulable state: from basic science to clinical practice. Pathophysiol Haemost Thromb 2003/2004; 33: 282-9.
2 Lip GYH, Varma C. Anticoagulation plus aspirin following acute myocardial infarction: Yes or no ... and if the latter, why not?. Thromb Res. 2005 Nov 4; [Epub ahead of print] doi:10.1016/j.thromres.2005. 09.012.
3 Tsaloumas MD, Kirwan J, Vinall H. et al. Nine year follow-up study of morbidity and mortality in retinal vein occlusion. Eye 2000; 14: 821-7.
4 Lee KW, Lip GYH. Acute coronary syndromes: Virchow’s triad revisited. Blood Coagul Fibrinolysis 2003; 14: 605-25.
5 Prandoni P, Bilora F, Marchiori A. et al. An association between atherosclerosis and venous thrombosis. N Eng J Med 2003; 348: 1435-41.
6 Bova C, Marchiori A, Noto A. et al. Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. Thromb Haemost 2006; 132-6.
7 Blann AD, Lip GY. Venous thromboembolism. BMJ 2006; 332: 215-9.
8 Prandoni P, Bilora F, Marchiori A. et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003; 348: 1435-41.
9 Maier W, Altwegg LA, Corti R. et al. Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation 2005; 111: 1355-61.
10 Rus HG, Vlaicu R, Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 1996; 127: 263-71.
11 Rus HG, Niculescu F, Vlaicu R. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis 1991; 89: 247-54.
12 Reitsma PH, Rosendaal FR. Activation of innate immunity in patients with venous thrombosis: the Leiden Thrombophilia Study. J Thromb Haemost 2004; 02: 619-22.
13 van Aken BE, Reitsma PH, Rosendaal FR. Interleukin-8 and venous thrombosis: evidence for a role of inflammation in thrombosis. Br J Haematol 2002; 116: 173-7.
14 Lip PL, Blann AD, Jones AF. et al. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk. Eye 1998; 12: 245-51.
15 Ray JG, Mamdani M, Tsuyuki RT. et al. Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med 2001; 161: 1405-10.